BFRI · Biofrontera Inc
United States · RS rating 32 · As of 2026-11-03
| Price | 0.89 USD |
|---|---|
| 1-day change | +2.3% |
| RS rating (overall / 1M / 3M / 12M) | 32 / 56 / 22 / 37 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 33 / 34 / 52 |
| Industry group (rank) | Medical-Ethical Drugs (94) |
| EPS growth Q/Q | +178.1% |
| Sales growth Q/Q | +144.7% |
| Distance from 52-week high | +44.7% |
| Market cap (USD) | $12.0M |